Market Research Life Sciences Market Research Diagnostics Market Research Medical Imaging Market Research Contrast Media Market Research

Contrast Media Market (Type: Iodine-based Compounds, Barium Sulfate-bsed Compounds, Gadolinium-based Compounds, and Microbubbles/Microspheres; Application: Oncology, Cardiology, Neurology, and Others) – Global Industry Analysis, Size, Share, Growth, Trend

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 191 Pages Transparency Market Research Pvt. Ltd. November, 2023 TNPR18404475
Best Price Guarantee
Price from $5,795
Length 191 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date November, 2023
SKU TNPR18404475

Contrast Media Market (Type: Iodine-based Compounds, Barium Sulfate-bsed Compounds, Gadolinium-based Compounds, and Microbubbles/Microspheres; Application: Oncology, Cardiology, Neurology, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Contrast Media Market – Scope of Report

TMR’s report on the global contrast media market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global contrast media market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global contrast media market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the contrast media market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global contrast media market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global contrast media market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global contrast media market.

The report delves into the competitive landscape of the global contrast media market. Key players operating in the global contrast media market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global contrast media market profiled in this report.

Key Questions Answered in Global contrast media Market Report
  • What is the sales/revenue generated by contrast media across all regions during the forecast period?
  • What are the opportunities in the global contrast media market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Contrast Media Market – Research Objectives and Research Approach

The comprehensive report on the global contrast media market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global contrast media market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global contrast media market.


1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Contrast Media Market
4. Market Overview
4.1. Market Segmentation
  4.1.1. Segment Definition
  4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. Global Contrast Media Market Analysis and Forecast, 2022-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Types of Diagnostic Imaging Tests
5.3. COVID-19 Pandemic Impact on Industry
6. Contrast Media Market Analysis and Forecast, by Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
  6.3.1. Iodine-based Compounds
  6.3.2. Barium Sulfate-based Compounds
  6.3.3. Gadolinium-based Compounds
  6.3.4. Microbubbles/Microspheres
6.4. Market Attractiveness, by Type
7. Contrast Media Market Analysis and Forecast, by Administration
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Administration, 2017–2031
  7.3.1. Oral
  7.3.2. Rectal
  7.3.3. Intravenous/Intrarterial
  7.3.4. Others
  7.3.5. 7.4 Market Attractiveness, by Administration
8. Global Contrast Media Market Analysis and Forecast, by Imaging Modality
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Imaging Modality, 2017–2031
  8.3.1. CT/X-Ray
  8.3.2. Ultrasound
  8.3.3. MRI
  8.3.4. Others
8.4. Market Attractiveness, by Imaging Modality
9. Global Contrast Media Market Analysis and Forecast, by Application
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017–2031
  9.3.1. Oncology
  9.3.2. Cardiology
  9.3.3. Neurology
  9.3.4. Others
9.4. 9.4 Market Attractiveness, by Application
10. Global Contrast Media Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
  10.2.1. North America
  10.2.2. Europe
  10.2.3. Asia Pacific
  10.2.4. Latin America
  10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Contrast Media Market Analysis and Forecast
11.1. Introduction
  11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
  11.2.1. Iodine-based Compounds
  11.2.2. Barium Sulfate-based Compounds
  11.2.3. Gadolinium-based Compounds
  11.2.4. Microbubbles/Microspheres
11.3. Market Attractiveness, by Type
11.4. Market Value Forecast, by Administration, 2017–2031
  11.4.1. Oral
  11.4.2. Rectal
  11.4.3. Intravenous/Intrarterial
  11.4.4. Others
11.5. Market Attractiveness, by Administration
11.6. Market Value Forecast, by Imaging Modality, 2017–2031
  11.6.1. CT/X-Ray
  11.6.2. Ultrasound
  11.6.3. MRI
  11.6.4. Others
11.7. Market Attractiveness, by Imaging Modality
11.8. Market Value Forecast, by Application, 2017–2031
  11.8.1. Oncology
  11.8.2. Cardiology
  11.8.3. Neurology
  11.8.4. Others
11.9. Market Attractiveness, by Application
11.10. Market Value Forecast, by Country, 2022–2031
  11.10.1. U.S.
  11.10.2. Canada
11.11. Market Attractiveness Analysis
  11.11.1. By Type
  11.11.2. By Administration
  11.11.3. By Imaging Modality
  11.11.4. Application
  11.11.5. By Country
12. Europe Contrast Media Market Analysis and Forecast
12.1. Introduction
  12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
  12.2.1. Iodine-based Compounds
  12.2.2. Barium Sulfate-based Compounds
  12.2.3. Gadolinium-based Compounds
  12.2.4. Microbubbles/Microspheres
12.3. Market Attractiveness, by Type
12.4. Market Value Forecast, by Administration, 2017–2031
  12.4.1. Oral
  12.4.2. Rectal
  12.4.3. Intravenous/Intrarterial
  12.4.4. Others
12.5. Market Attractiveness, by Administration
12.6. Market Value Forecast, by Imaging Modality, 2017–2031
  12.6.1. CT/X-Ray
  12.6.2. Ultrasound
  12.6.3. MRI
  12.6.4. Others
12.7. Market Attractiveness, by Imaging Modality
12.8. Market Value Forecast, by Application, 2017–2031
  12.8.1. Oncology
  12.8.2. Cardiology
  12.8.3. Neurology
  12.8.4. Others
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by Country/Sub-region, 2022–2031
  12.10.1. Germany
  12.10.2. U.K.
  12.10.3. France
  12.10.4. Italy
  12.10.5. Spain
  12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
  12.11.1. By Type
  12.11.2. By Administration
  12.11.3. By Imaging Modality
  12.11.4. By Application
  12.11.5. By Country/Sub-region
13. Asia Pacific Contrast Media Market Analysis and Forecast
13.1. Introduction
  13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
  13.2.1. Iodine-based Compounds
  13.2.2. Barium Sulfate-based Compounds
  13.2.3. Gadolinium-based Compounds
  13.2.4. Microbubbles/Microspheres
13.3. Market Attractiveness, by Type
13.4. Market Value Forecast, by Administration, 2017–2031
  13.4.1. Oral
  13.4.2. Rectal
  13.4.3. Intravenous/Intrarterial
  13.4.4. Others
13.5. Market Attractiveness, by Administration
13.6. Market Value Forecast, by Imaging Modality, 2017–2031
  13.6.1. CT/X-Ray
  13.6.2. Ultrasound
  13.6.3. MRI
  13.6.4. Others
13.7. Market Attractiveness, by Imaging Modality
13.8. Market Value Forecast, by Application, 2017–2031
  13.8.1. Oncology
  13.8.2. Cardiology
  13.8.3. Neurology
  13.8.4. Others
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
  13.10.1. China
  13.10.2. Japan
  13.10.3. India
  13.10.4. Australia & New Zealand
  13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
  13.11.1. By Type
  13.11.2. By Administration
  13.11.3. By Imaging Modality
  13.11.4. By Application
  13.11.5. By Country/Sub-region
14. Latin America Contrast Media Market Analysis and Forecast
14.1. Introduction
  14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
  14.2.1. Iodine-based Compounds
  14.2.2. Barium Sulfate-based Compounds
  14.2.3. Gadolinium-based Compounds
  14.2.4. Microbubbles/Microspheres
14.3. Market Attractiveness, by Type
14.4. Market Value Forecast, by Administration, 2017–2031
  14.4.1. Oral
  14.4.2. Rectal
  14.4.3. Intravenous/Intrarterial
  14.4.4. Others
14.5. Market Attractiveness, by Administration
14.6. Market Value Forecast, by Imaging Modality, 2017–2031
  14.6.1. CT/X-Ray
  14.6.2. Ultrasound
  14.6.3. MRI
  14.6.4. Others
14.7. Market Attractiveness, by Imaging Modality
14.8. Market Value Forecast, by Application, 2017–2031
  14.8.1. Oncology
  14.8.2. Cardiology
  14.8.3. Neurology
  14.8.4. Others
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
  14.10.1. Brazil
  14.10.2. Mexico
  14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
  14.11.1. By Type
  14.11.2. By Administration
  14.11.3. By Imaging Modality
  14.11.4. By Application
  14.11.5. By Country/Sub-region
15. Middle East & Africa Contrast Media Market Analysis and Forecast
15.1. Introduction
  15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
  15.2.1. Iodine-based Compounds
  15.2.2. Barium Sulfate-based Compounds
  15.2.3. Gadolinium-based Compounds
  15.2.4. Microbubbles/Microspheres
15.3. Market Attractiveness, by Type
15.4. Market Value Forecast, by Administration, 2017–2031
  15.4.1. Oral
  15.4.2. Rectal
  15.4.3. Intravenous/Intrarterial
  15.4.4. Others
15.5. Market Attractiveness, by Administration
15.6. Market Value Forecast, by Imaging Modality, 2017–2031
  15.6.1. CT/X-Ray
  15.6.2. Ultrasound
  15.6.3. MRI
  15.6.4. Others
15.7. Market Attractiveness, by Imaging Modality
15.8. Market Value Forecast, by Application, 2017–2031
  15.8.1. Oncology
  15.8.2. Cardiology
  15.8.3. Neurology
  15.8.4. Others
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
  15.10.1. GCC Countries
  15.10.2. South Africa
  15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
  15.11.1. By Type
  15.11.2. By Administration
  15.11.3. By Imaging Modality
  15.11.4. By Application
  15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
  16.3.1. GE Healthcare
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
  16.3.2. Bayer AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
  16.3.3. Bracco Diagnostic, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
  16.3.4. Guerbet Group
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
  16.3.5. Lantheus Medical Imaging, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
  16.3.6. nanoPET Pharma GmbH
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
  16.3.7. Subhra Pharma Pvt. Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
  16.3.8. Spago Nanomedical AB
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings